These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14980192)

  • 1. Evaluation of montelukast in 8 to 14 year old children with mild persistent asthma and compared with inhaled corticosteroids.
    Karaman O; Sünneli L; Uzuner N; Islekel H; Turgut CS; Köse S; Tezcan D; Coker C; Erbayraktar Z
    Allergol Immunopathol (Madr); 2004; 32(1):21-7. PubMed ID: 14980192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
    Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
    Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
    Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK
    J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
    Williams B; Noonan G; Reiss TF; Knorr B; Guerra J; White R; Matz J
    Clin Exp Allergy; 2001 Jun; 31(6):845-54. PubMed ID: 11422148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.
    Yurdakul AS; Taci N; Eren A; Sipit T
    Respir Med; 2003 Dec; 97(12):1313-9. PubMed ID: 14682413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast: a review of its therapeutic potential in persistent asthma.
    Jarvis B; Markham A
    Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spotlight on montelukast in asthma in children 2 to 14 years of age.
    Muijsers RB; Noble S
    Am J Respir Med; 2002; 1(3):225-8. PubMed ID: 14720060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
    Leigh R; Vethanayagam D; Yoshida M; Watson RM; Rerecich T; Inman MD; O'Byrne PM
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1212-7. PubMed ID: 12403690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.
    Vaquerizo MJ; Casan P; Castillo J; Perpiña M; Sanchis J; Sobradillo V; Valencia A; Verea H; Viejo JL; Villasante C; Gonzalez-Esteban J; Picado C;
    Thorax; 2003 Mar; 58(3):204-10. PubMed ID: 12612294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
    Szefler SJ; Carlsson LG; Uryniak T; Baker JW
    J Allergy Clin Immunol Pract; 2013 Jan; 1(1):58-64. PubMed ID: 24229823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.
    Zhang J; Yu C; Noonan G; Reiss TF
    Clin Ther; 2002 Apr; 24(4):574-82. PubMed ID: 12017402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
    Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A
    Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.
    Knorr B; Matz J; Bernstein JA; Nguyen H; Seidenberg BC; Reiss TF; Becker A
    JAMA; 1998 Apr; 279(15):1181-6. PubMed ID: 9555757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.
    Muijsers RB; Noble S
    Paediatr Drugs; 2002; 4(2):123-39. PubMed ID: 11888359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
    Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
    Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
    Ceylan E; Gencer M; Aksoy S
    Respiration; 2004; 71(6):594-601. PubMed ID: 15627870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.